Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 β-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 11, Issue 3, 2008, Pages 45-62

  Jia, Jessica X ^a   Wasan, Kishor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL; DRUG DERIVATIVE; ESTRADIOL; ESTRADIOL 17 BETA GLUCURONIDE; ESTRADIOL-17 BETA-GLUCURONIDE; EXCIPIENT; GLYCEROL OLEATE; GLYCEROL STEARATE; MONOACYLGLYCEROL; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; PALMITOYL GLYCEROL; RHODAMINE 123; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; EXCIPIENTS; GENE EXPRESSION REGULATION; GLYCERIDES; HUMANS; MONOGLYCERIDES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RHODAMINE 123;

EID: 58149133945     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j33s3z     Document Type: Article

References (46)

1. Buxton, IL. Pharmacodynamics: The Dynamics of 2 Drug Absorption, Distribution, Action, and Elimination, in Brunton LL; Lazo JS; Parker K (eds), Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th ed., McGraw-Hill Companies, INC, USA, pp 1-40, 2006.
2. Neslihan R. Gursoy and Simon Benita. Selfemulsifying Drug Delivery Systems (SEDDS) for Improved Oral Delivery of Lipophilic Drugs. Biomed Pharmacother, 58:173-182, 2004.
3. Christopher J.H. Porter, Natalie L. Trevaskis and William N. Charman. Lipids and Lipid-based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs. Nat Rev Drug Discov, 6:231-248, 2007.
4. Colin W. Pouton. Self-emulsifying Drug Delivery Systems: Assessment of the Efficiency of Emulsification. Int J Pharm, 27:335-348, 1985.
5. Colin W. Pouton. Formulation of Selfemulsifying Drug Delivery Systems. Adv. Drug Deliv Rev, 25:47-58, 1997.
6. William N. Charman, Christopher J.H. Porter, Sabena Mithani and Jennifer B. Dressman. Physiochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: the Role of Lipids and pH. J Pharm Sci, 86:269-282, 1997.
7. Christopher J.H. Porter and William N. Charman. Intestinal Lymphatic Drug Transport: an Update. Adv Drug Deliv Rev, 50:61-80, 2001.
8. Verica Risovic, Kristina Sachs-Barrable, Michael Boyd and Kishor M. Wasan. Potential Mechanisms by which Peceol Increases the Gastrointestinal Absorption of Amphotericin B. Drug Dev Ind Pharm, 30:767-774, 2004.
9. Kristina Sachs-Barrable, Andrea Thamboo, Stephen D. Lee and Kishor M. Wasan. Lipid Excipients Peceol and Gelucire 44/14 Decrease P-glycoprotein Mediated Efflux of Rhodamine 123 Partially Due to Modifying P-glycoprotein Protein Expression within Caco-2 cells. J Pharm Pharm Sci, 10:319-331, 2007.
10. Pang, K. S., Liu, L. and Sun, H. Interaction of Drug Transporters with Excipients, in Wasan KM (ed), Role of Lipid Excipients in Modifying Oral and Parenteral Drug Delivery, John Wiley & Sons, Inc., Hoboken, NJ, pp. 1-31, 2006
11. Sandy K. Pang. Modeling of Intestinal Drug Absorption: Roles of Transporters and Metabolic Enzymes. Drug Metab Dispos, 31:1507-1519, 2003.
12. Michael Dean, Yannick Hamon and Giovanna Chimini. The Human ATP-Binding Cassette (ABC) Transporter Superfamily. J Lipid Res, 42:1007-1017, 2001.
13. David J. Hauss, Steven E. Fogal, James V. Ficorilli, Caswall A. Price, Tapon Roy, Andrew A. Jayaraj and James J. Keirns. Lipid-based Delivery Systems for Improving the Bioavailability and Lymphatic Transport of a Poorly Water-soluble LTB4 Inhibitor. J Pharm Sci, 87:164-169, 1998.
14. Tomoko Konishi, Hideo Satsu, Yasuo Hatsugai, Koichi Aizawa, Takahiro Inakuma, Shinji Nagata, Sho-hei Sakuda, Hiromichi Nagasawa and Makoto Shimizu. A Bitter Melon Extract Inhibits the P-glycoprotein Activity in Intestinal Caco-2 Cells: Monoglyceride as Active Compound. Biofactors, 22:71-74, 2004.
15. Ulrich Hoffmann and Heyo K. Kroemer. The ABC Transporters MDR1 and MRP2 Multiple Functions in Disposition of Xenobiotics and Drug Resistance. Drug Metab Rev, 36:669-701, 2004.
16. Gary D. Kruh and Martin G. Belinsky. The MRP Family of Drug Efflux Pumps. Oncogene, 22:7537-7552, 2003.
17. Supratim Choudhuri and Curtis D. Klaassen. Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters. Int J Toxicol, 25:231-259, 2006.
18. Gary Kruh, Martin Belinsky, James Gallo and Kun M. Lee. Physiological and Pharmacological Functions of Mrp2, Mrp3 and Mrp4 as Determined from Recent Studies on Gene-disrupted Mice. Cancer Metastasis Rev, 26:5-14, 2007.
19. Horton, H.R.; Moran, L.A.; Ochs, R.S. and Scrimgeour, K.G., Principles of Biochemistry, Prentice-Hall/Pearson, Upper Saddle River, NJ, USA, 2002.
20. Elena V. Batrakova, Shu Li, Yili Li, Valery Y. Alakhov and Alexander V. Kabanov. Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters. Pharm Res, 21:2226-2233, 2004.
21. Ronit Regev, Yehuda G. Assaraf and Gera D. Eytan. Membrane Fluidization by Ether, other Anesthetics, and Certain Agents Abolishes Pglycoprotein ATPase Activity and Modulates Efflux from Multidrug-resistant Cells. Eur J Biochem, 259:18-24, 1999.
22. Annette Braun, Sibylle Hämmerle, Kayoshi Suda, Barbara Rothen-Rutishauser, Maja Günthert, Stefanie D. Krämer and Heidi Wunderli-Allenspach. Cell Cultures as Tools in Biopharmacy. Eur J Pharm Sci, 11:S51-S60, 2000.
23. Allen R. Hilgers, Robert A. Conradi and Philip S. Burton. Caco-2 Cell Monolayers as a Model for Drug Transport across the Intestinal Mucosa. Pharm Res, 7:902-910, 1990.
24. Jan Taipalensuu, Hans Törnblom, Greger Lindberg, Curt Einarsson, Folke Sjöqvist, Håkan Melhus, Per Garberg, Brita Sjöström, Bo Lundgren and Per Artursson. Correlation of Gene Expression of Ten Drug Efflux Proteins of the ATP-binding Cassette Transporter Family in Normal Human Jejunum and in Human Intestinal Epithelial Caco-2 Cell Monolayers. J Pharmacol Exp Ther, 299:164-170, 2001.
25. Ina Hubatsch, Eva G.E. Ragnarsson and Per Artursson. Determination of Drug Permeability and Prediction of Drug Absorption in Caco-2 Monolayers. Nat Protoc, 2:2111-2119, 2007.
26. William J. Welch. Mammalian Stress Response: Cell Physiology, Structure/Function of Stress Proteins, and Implications for Medicine and Disease. Physiol Rev, 72:1063-1081, 1992.
27. Guido Kroemer, Bruno Dallaporta and Michèle Resche-Rigon. The Mitochondrial Death/Life Regulator in Apoptosis and Necrosis. Annu Rev Physiol, 60:619-642, 1998.
28. Peter R. Twentyman, Tracy Rhodes, and Simon Rayner. A Comparison of Rhodamine 123 Accumulation and Efflux in Cells with Pglycoprotein-mediated and MRP-associated Multidrug Resistance Phenotypes. Eur J Cancer, 9:1360-1369, 1994).
29. Malcolm Webb, Cary L. Raphael, Heinke Asbahr, Wendy N. Erber and Brian F. Meyer. The Detection of Rhodamine 123 Efflux at Low Levels of Drug Resistance. Br J Haematol, 93:650-655, 1996.
30. Seiji Miyauchi, Masaki Komatsubara and Naoki Kamo. In Archaebacteria, There is a Doxorubicin Efflux Pump Similar to Mammalian Pglycoprotein. Biochim Biophys Acta, 1110:144-150, 1992.
31. Matthew D. Troutman and Dhiren R. Thakker. Rhodamine 123 Requires Carrier-mediated Influx for its Activity as a P-glycoprotein Substrate in Caco-2 Cells. Pharm Res, 20:1192-1199, 2003.
32. Lincoln V. Johnson, Marcia L. Walsh and Lan B. Chen. Localization of Mitochondria in Living Cells with Rhodamine 123. Proc Natl Acad Sci, 77:990-994, 1980.
33. Omar Alqawi, Susan Bates, and Elias Georges. Arginine482 to Threonine Mutation in the Breast Cancer Resistance Protein ABCG2 Inhibits Rhodamine 123 Transport while Increasing Binding. Biochem J, 382:711-716, 2004.
34. Bakela Nare, Roger K. Prichard and Elias Georges. Characterization of Rhodamine 123 Binding to P-glycoprotein in Human Multidrugresistant Cells. Mol Pharmacol, 45:1145-1152, 1994.
35. Roni Daoud, Christina Kast, Philippe Gros and Elias Georges. Rhodamine 123 Binds to Multiple Sites in the Multidrug Resistance Protein (MRP1). Biochemistry. 39:15344-15352, 2000.
36. Lale A. Doganab, Ollivier Legrandb, Anne-Marie Faussatb, Jean-Yves Perrotb and Jean-Pierre Marieb. Evaluation and Comparison of MRP1 Activity with Three Fluorescent Dyes and Three Modulators in Leukemic Cell Lines. Leuk Res, 28:619-622, 2004.
37. Constanze Hilgendorf, Gustav Ahlin, Annick Seithel, Per Artursson, Anna-Lena Ungell, and Johan Karlsson. Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines. Drug Metab Dispos. 35:1333-1340, 2007.
38. Zhe-Sheng Chen, Elizabeth Hopper-Borge, Martin G. Belinsky, Irina Shchaveleva, Elena Kotova and Gary D. Kruh. Characterization of the Transport Properties of Human Multidrug Resistance Protein 7 (MRP7, ABCC10). Mol Pharmacol, 63:351-358, 2003.
39. Liyue Huang, Tim Hoffman and Mary Vore. Adenosine Triphosphate-dependent Transport of Estradiol-17β (β-d-glucuronide) in Membrane Vesicles by MDR1 expressed in insect cells. Hepatology, 28:1371-1377, 1998.
40. Naoko Yoshida, Tappei Takada, Yoshikazu Yamamura, Isao Adachi, Hiroshi Suzuki and Junichi Kawakami. Inhibitory Effects of Terpenoids on Multidrug Resistance-Associated Protein 2-and Breast Cancer Resistance Proteinmediated Transport. Drug Metab Dispos, 2008.
41. Hiroyuki Kusuhara and Yuichi Sugiyama. Active Efflux Across the Blood-brain Barrier: Role of the Solute Carrier Family. NeuroRx, 2:73-85, 2005.
42. Rémon A. M. H. van Aubel, Marcel A. van Kuijck, Jan B. Koenderink, Peter M. T. Deen, Carel H. van Os and Frans G. M. Russel. Adenosine Triphosphate-Dependent Transport of Anionic Conjugates by the Rabbit Multidrug Resistance-Associated Protein Mrp2 Expressed in Insect Cells. Mol Pharmacol, 53:1062-1067, 1998.
43. Hajime Takikawa, Ryo Yamazaki, Naoyo Sano and Masami Yamanaka. Biliary Excretion of Estradiol-17 beta-glucuronide in the Rat. Hepatology, 23:607-613, 1996.
44. Chih-Hao Lee and Jorge Plutzky. Liver X Receptor Activation and High-density Lipoprotein Biology: a Reversal of Fortune? Circulation, 113:5-8, 2006.
45. Ajay Chawla, Joyce J. Repa, Ronald M. Evans and David J. Mangelsdorf. Nuclear Receptors and Lipid Physiology: Opening the X-Files. Science, 294:1866-1870, 2001.
46. Deferme, S.; Annaert, P.; Augustijns, P In Vitro Screening Models to Assess Intestinal Drug Absorption and Metabolism, in Ehrhardt C and Kim KJ (eds), Drug Absorption Studies, Springer, US, pp 182-215, 2008.